Purchases and Sales Made in Q4 2024 in Crinetics Pharmaceuticals, Inc. (CRNX)
This table provides information about the institutional ownership of Crinetics Pharmaceuticals, Inc. (CRNX) during Q4 2024. The information is specifically focused on institutions that hold shares of Crinetics Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 06, 2025
Q4 2024
|
Victory Capital Management Inc
|
SELL
|
- |
-61.9K- 18.03% |
$3.14M - $3.76M
|
281K
$8.49M
|
|
|
Feb 14, 2025
Q4 2024
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
SELL
|
- |
-65.7K- 6.14% |
$3.33M - $3.98M
|
1M
$30.2M
|
|
|
Feb 11, 2025
Q4 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-65.8K- 8.36% |
$3.33M - $3.99M
|
721K
$21.8M
|
|
|
Feb 14, 2025
Q4 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-68.3K- 23.72% |
$3.46M - $4.14M
|
220K
$6.62M
|
|
|
Feb 13, 2025
Q4 2024
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-79.1K- 35.8% |
$4.01M - $4.8M
|
142K
$4.28M
|
|
|
Jan 24, 2025
Q4 2024
|
Jennison Associates LLC
|
SELL
|
- |
-85.3K- 3.05% |
$4.32M - $5.17M
|
2.71M
$81.7M
|
|
|
Feb 14, 2025
Q4 2024
|
Cormorant Asset Management, LP
Boston, MA |
SELL
|
- |
-100K- 9.09% |
$5.07M - $6.07M
|
1M
$30.2M
|
|
|
Feb 13, 2025
Q4 2024
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
SELL
|
- |
-114K- 18.51% |
$5.78M - $6.93M
|
503K
$15.2M
|
|
|
Feb 14, 2025
Q4 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-122K- 94.29% |
$6.19M - $7.42M
|
7.4K
$223K
|
|
|
Feb 14, 2025
Q4 2024
|
Eventide Asset Management, LLC
Boston, MA |
SELL
|
- |
-126K- 17.15% |
$6.39M - $7.65M
|
609K
$18.4M
|
|
|
Feb 14, 2025
Q4 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-130K- 96.51% |
$6.61M - $7.91M
|
4.72K
$142K
|
|
|
Feb 14, 2025
Q4 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-161K- 24.12% |
$8.13M - $9.74M
|
505K
$15.2M
|
|
|
Feb 14, 2025
Q4 2024
|
Stanley Druckenmiller
Duquesne Family Office LLC | New York, Ny
|
SELL
|
- |
-186K- 60.29% |
$9.44M - $11.3M
|
123K
$3.7M
|
|
|
Feb 14, 2025
Q4 2024
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-540K- 74.54% |
$27.4M - $32.8M
|
185K
$5.57M
|
|
|
Feb 14, 2025
Q4 2024
|
Paradigm Biocapital Advisors LP
New York, NY |
SELL
|
- |
-606K- 24.08% |
$30.7M - $36.8M
|
1.91M
$57.6M
|